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Several environmental factors, such as expo-
sure to environmental tobacco smoke (1–5),
dampness and mold problems (6–11), house
dust mites (12–14), emissions from PVC
flooring (15–16), and electric heating (17)
have been suggested to increase the risk of
asthma or asthmalike symptoms and signs in
childhood. A central role of genetic factors
in the development of asthma is suggested
by evidence that family history of allergic
diseases increases the risk of asthma (18).
We hypothesized that the joint effect of
genetic propensity to asthma and environ-
mental exposure on the risk of childhood
asthma is more than expected on the basis of
their independent effects. This phenomenon
is commonly described as effect modiﬁcation
(19) or gene by environment interaction
(20–21) and it suggests that some genetic
markers impose susceptibility to the effects
of environmental factors. We addressed the
question of gene by environment interaction
using the Oslo Birth Cohort, which was
established 1992–1993 to study environ-
mental determinants of respiratory health in
children with special emphasis on asthma
and asthma-related symptoms and signs
(4,11,16,22–24). We assumed that parents
with asthma or allergic rhinitis give their
children a large set of genes that increase the
child’s susceptibility to the effects of envi-
ronmental factors on asthma. More specifi-
cally, we selected environmental tobacco
smoke, one of the best established environ-
mental determinants of childhood asthma,
and used parental history of allergic diseases
as a measure of genetic propensity to asthma
to study independent and joint effects of
parental atopy and early-life exposure to
environmental tobacco smoke. 
Methods
Study population. The source population
included children born in the two main birth
clinics in Oslo during 15 months in
1992–1993. The eligibility criteria and data
collection procedures for the children’s ﬁrst
two years are described in detail elsewhere
(4). Information on the child’s health and
environmental exposures was collected from
parents by self-administered questionnaires at
the child’s birth and when the child was 6
months, 12 months, 18 months, and 24
months of age. The 2-year follow-up rate was
81% (n = 3,048) (4). In November 1996, we
conducted a 4-year follow-up in connection
with a survey directed at all the 4-year-old
children living in Oslo and the members of
the birth cohort living outside Oslo (23–24).
All phases of the study were approved by 
the Norwegian Data Inspectorate (Oslo,
Norway). In the present study, we focused
only on the 3,048 children with information
on respiratory health from the ﬁrst 2 years of
their life. We obtained a correct mailing
address for 2,930 of these children and
received a completed questionnaire from
families of 2,594 (89%) children. Infor-
mation on current asthma was available for
2,531 children, who constituted the study
population (Table 1). These children had a
mean age of 4.3 years (SD 0.3). 
Health outcomes. The primary outcomes
were bronchial obstruction in the first 2
years of life and current asthma. Current
asthma was deﬁned on the basis of answer to
the 4-year follow-up questionnaire as a his-
tory of asthma diagnosed by a physician and
experience of symptoms of asthma during
the previous 12 months. Bronchial obstruc-
tion in the ﬁrst 2 years of life was deﬁned as
two or more episodes with symptoms and
signs of obstruction or one episode lasting
more than one month (4). We also used a
combination of bronchial obstruction in the
ﬁrst 2 years of life and current asthma as the
secondary outcome.
Genetic and environmental determi-
nants of interest. Parental atopy was deﬁned
as a history of maternal or paternal asthma
or hay fever. Information on parental asthma
and hay fever was collected in the birth ques-
tionnaire. We based our assessment of expo-
sure to environmental tobacco smoke on
questionnaire information at birth about the
smoking habits of the parents and other per-
sons living in the child’s home. Use of infor-
mation on smoking habits at birth prevented
bias that could be introduced by a change in
parental smoking habits caused by appear-
ance of symptoms and signs of asthma in the
child. We evaluated the validity of question-
naire information by using the levels of coti-
nine and thiocyanate in umbilical cord
serum in 202 randomly selected mothers.
There was an excellent agreement between
high and low levels of biomarkers and daily
and nonsmoking mothers (25).
Covariates. We obtained information on
potential confounders from the hospital
records and the questionnaires. The covari-
ates in the present analyses included sex of
the child, maternal age at delivery, length of
breast-feeding, care in a day care center at 1
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We hypothesized that the joint effect of genetic propensity to asthma and exposure to environ-
mental tobacco smoke on the risk of childhood asthma is greater than expected on the basis of
their independent effects. We performed a population-based 4-year cohort study of 2,531 chil-
dren born in Oslo, Norway. We collected information on the child’s health and environmental
exposures at birth and when the child was 6, 12, 18, and 24 months and 4 years of age. The out-
comes of interest were bronchial obstruction during the ﬁrst 2 years and asthma at the age of 4
years. Parental atopy was defined as a history of maternal or paternal asthma or hay fever.
Exposure to environmental tobacco smoke was deﬁned on the basis of questionnaire information
on household smokers at birth. In logistic regression analysis adjusting for confounding, parental
atopy alone increased the risk of bronchial obstruction [odds ratio 1.62; 95% conﬁdence interval
(CI) 1.10–2.40] and asthma (1.66; 95% CI, 1.08–2.54). In children without parental atopy,
there was little effect of exposure to environmental tobacco smoke on bronchial obstruction
(1.29; 95% CI, 0.88–1.89) and asthma (0.84; 95% CI, 0.53–1.34). The presence of parental
atopy and exposure had a substantial effect both on bronchial obstruction (2.88; 95% CI,
1.91–4.32) and asthma (2.68; 95% CI, 1.70–4.22). The results are consistent with the hypothe-
sized joint effect of parental atopy and exposure to environmental tobacco smoke. This phenome-
non—denoted as effect modiﬁcation of environmental exposure by genetic constitution, or gene
by environment interaction—suggests that some genetic markers could indicate susceptibility to
environmental factors. Key words: asthma, atopy, gene by environment interaction, tobacco
smoke. Environ Health Perspect 109:579–582 (2001). [Online 22 May 2001]
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family income, and single parenthood.
Length of breast-feeding was categorized as
0–6 months and > 6 months. 
Statistical methods. First, we studied
independent and joint effects of parental
atopy and exposure to environmental
tobacco smoke on an additive scale (26,27).
We compared the risk of experiencing
bronchial obstruction in the ﬁrst 2 years and
asthma at 4 years of age in four exposure cat-
egories: a) no parental atopy and no expo-
sure to environmental tobacco smoke (R00,
reference category); b) parental atopy and no
exposure to environmental tobacco smoke
(R10); c) no parental atopy and exposure to
environmental tobacco smoke (R01); and d)
parental atopy and exposure to environmen-
tal tobacco smoke (R11). On an additive
scale, we quantified the interaction (IA) or
joint effect of two factors by calculating the
risk that is more than expected based on the
independent effects of these factors (26): 
IA = (R11 – R00) – (R10 – R00) 
– (R01 – R00).
Second, we used the odds ratio as a mea-
sure of effect and estimated adjusted odds
ratios applying logistic regression analysis.
The odds ratios were adjusted for the
covariates described above. We also assessed
how each allergic disease, including maternal
and paternal asthma and hay fever, alone
predicts the risk of developing the primary
outcomes. To assess the joint effect of
parental atopy and exposure to environmen-
tal tobacco smoke, we calculated odds ratios
contrasting each of the three exposure cate-
gories to the reference category. Estimates
for the independent effects of parental atopy
and environmental tobacco smoke exposure
and their joint effect was derived from the
same logistic regression model adjusting for
the covariates. 
Results
Study population. The characteristics and
early exposure of the children followed for 4
years and those of the baseline and 2-year
cohort were similar (Table 1). A total of 225
children (8.9%) experienced bronchial
obstruction during the first 2 years of life,
and 164 children (6.5%) had current asthma
at the age of 4 years.
Independent effects of parental atopy and
exposure to environmental tobacco smoke.
Early-life exposure to environmental tobacco
smoke increased the risk of bronchial obstruc-
tion [adjusted odds ratio 1.43; 95% confi-
dence interval (CI), 1.07–1.90], but had little
effect on the risk of asthma in the complete
cohort (1.10; 95% CI, 0.79–1.53), as shown
in Table 2. Parental atopy was a significant
determinant of both bronchial obstruction
(1.84; 95% CI, 1.39–2.44) and asthma (2.17;
95% CI, 1.57–3.00). Table 2 also presents
maternal and paternal asthma and hay fever as
predictors of bronchial obstruction and
asthma. Maternal asthma was the strongest
predictor of both bronchial obstruction
(adjusted odds ratio 2.65; 95% CI,
1.72–4.10) and asthma (adjusted odds ratio
3.11; 95% CI, 1.97–4.90). The association of
paternal asthma was clearly weaker both with
the risk of bronchial obstruction (adjusted
odds ratio 1.52; 95% CI 0.91–2.53) and
asthma (adjusted odds ratio 1.57; 95% CI
0.88–2.82). 
Joint effect of parental atopy and expo-
sure to environmental tobacco smoke. Tables
3 and 4 show risks of bronchial obstruction
and asthma in the four categories. On addi-
tive scale, the excess risk of bronchial
obstruction caused by parental atopy was
0.033 and that caused by environmental
tobacco smoke exposure was 0.024, and the
effect caused by interaction of these two
determinants was 0.044 (Table 3). In terms
of relative risks, parental atopy alone
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Table 1. Characteristics of the Oslo Birth Cohort at birth and at 2- and 4-year follow-up surveys.
At birth 2-Year cohort 4-Year cohort
Characteristic (n = 3,754) (n = 2,985) (n = 2,531)
Sex, male  51.8 51.3 51.3
Parental atopy 33.7 33.9 34.6
Breast-feeding after 6 months – 70.1 71.2
Maternal age at delivery (years)
< 25  12.2 10.5 9.5
25–29 36.2 35.7 35.5
> 30 51.6 53.8 55.5
Maternal education (years)
< 12 7.3 5.6 4.7
12–15 39.5 38.0 36.4
> 15 53.2 56.4 58.9
Family income per year (Norwegian kronor)
< 200,000 17.0 14.1 13.2
200,000–500,000 64.7 66.8 66.8
> 500,000 18.3 19.1 20.0
Single parenthood 11.4 7.7 7.1
Care in a day care center at 1 yeara – 15.0 15.0
Early-life exposure to environmental 46.3 41.3 39.8
tobacco smoke
Values shown are percentages. Number of subjects with missing data is very low: In the baseline questionnaire, 78 (fam-
ily income per year) did not respond; in the 2-year questionnaire, 101 (breast-feeding); and in the 4-year questionnaire, 79
(breast-feeding). 
a>10 hr per week. 
Table 2. Independent effects of parental atopy and exposure environmental tobacco smoke on the risks of
bronchial obstruction by 2 years of age and asthma at 4 years of age.
Bronchial obstruction
by 2 years of age Asthma at 4 years of age
Crude Adjusteda Crude Adjusteda
No. Risk OR OR 95% CI Risk OR OR 95% CI
Environmental tobacco smoke
Early-life exposure
No 1,520 0.075 0.061
Yes 1,003 0.111 1.53 1.43 1.07–1.90 0.071 1.17 1.10 0.79–1.53
Parental allergic diseases
Parental atopy
(maternal or paternal) 
No 1,656 0.072 0.048
Yes 875 0.120 1.75 1.84 1.39–2.44 0.096 2.09 2.17 1.57–3.00
Maternal asthma
No 2,372 0.082 0.057
Yes 159 0.189 2.60 2.65 1.72–4.10 0.176 3.51 3.11 1.97–4.90
Maternal hay fever
No 2,149 0.086 0.060
Yes 382 0.107 1.28 1.39 0.97–2.00 0.089 1.52 1.66 1.11–2.48
Paternal asthma
No 2,384 0.086 0.063
Yes 147 0.129 1.67 1.52 0.91–2.53 0.095 1.57 1.57 0.88–2.82
Paternal hay fever
No 2,086 0.085 0.060
Yes 445 0.108 1.30 1.35 0.96–1.91 0.085 1.45 1.54 1.05–2.28
aLogistic regression controlling for sex, maternal age at delivery, maternal education, family income, single parenthood,
and length of breast-feeding.increased the risk of bronchial obstruction,
with an adjusted odds ratio of 1.62 (95%
CI, 1.10–2.40). The effect of environmental
tobacco smoke in children of nonatopic par-
ents was weaker: 1.29 (95% CI, 0.88–1.89).
The adjusted odds ratio of bronchial
obstruction was 2.88 (95% CI, 1.91–4.32)
in children with atopic heredity and expo-
sure to environmental tobacco smoke, com-
pared with children in the reference
category. The 95% CIs of these effect esti-
mates were exclusive, indicating that the
stronger effect of environmental tobacco
smoke in children of atopic parents could
not be explained by chance. 
The excess risk of asthma related to
parental atopy was 0.030, but the risk was
not related to environmental tobacco smoke
exposure in children without parental atopy
(Table 4). The interaction of parental atopy
and environmental tobacco smoke was
0.049. In logistic regression, parental atopy
without environmental tobacco smoke expo-
sure increased the risk of asthma with an
odds ratio of 1.66 (95% CI, 1.08–2.54), but
environmental tobacco smoke exposure with-
out atopy had no effect on the risk of asthma
(0.84; 95% CI, 0.53–1.34). The adjusted
odds ratio of asthma was 2.68 (95% CI,
1.70–4.22) in children with atopic heredity
and exposure to environmental tobacco
smoke compared with children in the refer-
ence category. Also for asthma, the 95% CIs
of these two effect estimates were exclusive.
In all, the adjusted odds ratios for the
four categories did not differ substantially
from the corresponding crude odds ratios,
which indicated that the joint effects in
additive scale are accurate (Tables 3 and 4). 
Finally, we defined an additional out-
come, early-onset asthma, which constituted
both experience of early-life bronchial
obstructions and presence of asthma at the
age of 4 years. Seventy-six children met these
outcome criteria. The effect of environmen-
tal tobacco smoke on this early-onset asthma
was 0.74 (95% CI, 0.35–1.58) in children
without parental atopy, and 3.86 (95% CI,
2.04–7.28) in children whose either or both
parents were atopic.
Discussion
The ﬁndings of our prospective cohort study
are consistent with the hypothesis that the
joint effect of parental atopy and early-life
exposure to environmental tobacco smoke
on the risk of childhood asthma is greater
than expected on the basis of their indepen-
dent effects. The results also indicated inde-
pendent effects of parental atopy on the risks
of both bronchial obstruction and asthma.
We found a small independent effect of
exposure to environmental tobacco smoke
on bronchial obstruction, but no effect on
asthma at age 4—the effect of environmental
tobacco smoke on asthma was seen mainly
among children of atopic parents.
Validity of results. A prospective cohort
study offers a suitable approach to assess the
effect of hereditary and early-life environ-
mental factors on development of asthma
later in life. We were able to follow 67% of
the 3,754 newborns for 4 years. Losses to
follow-up were not likely to compromise the
validity of the results because distributions of
parental atopy and exposure to environmen-
tal tobacco smoke at baseline were similar to
those of 2- and 4-year cohorts.
Information on environmental tobacco
smoke exposure and parental asthma was
based on parental reports. The exposure
information was collected before the onset of
the outcome of interest, so any bias due to
awareness of the disease of interest was
avoided. We evaluated the questionnaire
information on maternal smoking by bio-
marker concentrations in cord serum and
found that smoking habits were reported
accurately (25).
A committee of specialists evaluated data
from clinical examinations by specialists and
available health records and made the diag-
nosis of bronchial obstruction in the ﬁrst 2
years of life. To detect all the cases, we
reminded the parents with each follow-up
questionnaire to contact the project pediatri-
cian in case of respiratory problems, asked
outpatient clinics to refer all possible cases to
the project pediatrician, and contacted fami-
lies reporting respiratory symptoms in the
questionnaires. A physician-conducted tele-
phone interview with 100 parents of non-
symptomatic children revealed that no
episodes of bronchial obstruction had been
overlooked. The definition of current
asthma was based on a diagnosis of a physi-
cian and an experience of asthmalike symp-
toms and signs during the previous 12
months. Free access of families to health ser-
vices in Norway and our frequent contacts
with the families during the ﬁrst 2 years were
likely to minimize underdiagnosis of asthma.
Any misclassification of the outcomes was
likely to be nondifferential.
We were able to take into account most
known potential confounders such as sex,
length of breast-feeding, maternal age at deliv-
ery, care in a day care center at 1 year, and
indicators of socioeconomic status including
maternal education, family income, and sin-
gle parenthood. Adjustment did not change
the measure of effect substantially.
Definition of interaction. We used the
absolute effects on an additive scale in the
deﬁnition of interaction. This is justiﬁed by
the idea that the public health impact of
Children’s Health • ETS, hereditary atopy, and childhood asthma
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Table 3. Independent and joint effects of hereditary atopy and exposure to environmental tobacco smoke
on the risks of bronchial obstruction by 2 years of age.
Bronchial obstruction by 2 years of age
Risk Crude Adjusted
Exposure No. Risk differencea Interactione OR ORf 95% CI
No parental atopy 959 0.063 – – 1.00 1.00
No ETS exposure (R00)
(reference)
Parental atopy 561 0.096 0.033b – 1.60 1.62 1.10–2.40
No ETS exposure (R10)
No parental atopy 692 0.087 0.024c – 1.42 1.29 0.88–1.89
ETS exposure (R01)
Parental atopy 311 0.164 0.101d 0.044 2.94 2.88 1.91–4.32
ETS exposure (R11)
aRisk in exposure category minus risk in reference category. bR10–R00. cR01–R00. dR11–R00. e(R11–R00)–(R10–R00)–(R01–R00).
fLogistic regression controlling for sex, maternal age at delivery, maternal education, family income, single parenthood,
and length of breast-feeding.  
Table 4. Independent and joint effects of hereditary atopy and exposure to environmental tobacco smoke
on the risks of asthma at 4 years of age.
Asthma at 4 years of age
Risk Crude Adjusted
No. Risk differencea Interactione OR ORf 95% CI
No parental atopy 959 0.050 – – 1.00 1.00
No ETS exposure (R00)
(reference)
Parental atopy 561 0.080 0.030b – 1.66 1.66 1.08–2.54
No ETS exposure (R10)
No parental atopy 692 0.046 –0.004c – 0.92 0.84 0.53–1.34
ETS exposure (R01)
Parental atopy 311 0.125 0.075d 0.049 2.72 2.68 1.70–4.22
ETS exposure (R11)
aRisk in exposure category minus risk in reference category. bR10–R00. cR01–R00. dR11–R00. e(R11–R00)–(R10–R00)–(R01–R00).
fLogistic regression controlling for sex, maternal age at delivery, maternal education, family income, single parenthood,
and length of breast-feeding. independent effects and their possible inter-
action follows additive rather than, for
example, multiplicative scale (26,27). This
can be illustrated by a rough calculation of
excess number of children experiencing
bronchial obstruction caused by parental
atopy, exposure to environmental tobacco
smoke, and interaction of these factors from
the risk differences (Table 3). Parental atopy
resulted in 33 excess cases per 1,000 children
and exposure to environmental tobacco
smoke 24 excess cases per 1,000 children.
The independence of effects would implicate
57 additional cases in the presence of both
determinants. Table 3 indicates that children
with both parental asthma and exposure had
101 excess cases per 1,000 with asthma; on
additive scale the interaction represented 44
additional cases. 
Synthesis with previous knowledge.
Several recent studies have provided evi-
dence of the role of environmental tobacco
smoke as a determinant of childhood asthma
(1–4). A recent meta-analysis reported a
pooled estimate of 1.37 for the risk of
asthma if either parent smoked (5). Our
study provides additional conﬁrmation that
exposure to environmental tobacco smoke
increases the risk of childhood asthma,
although the effect is stronger in genetically
susceptible individuals. 
Our findings strengthen the evidence
that hereditary allergic diseases are important
determinants of childhood asthma, and are
consistent with a study by Mutius and col-
leagues (18). Maternal asthma was the
strongest determinant of both bronchial
obstruction and asthma at the age of 4 years.
These ﬁndings suggest strongly that genetic
background is an important determinant of
asthma. Because the pathophysiological and
clinical manifestations of asthma are
complex, studies of genetic markers have
focused on speciﬁc features (phenotypes) of
asthma, such as atopic immunoglobulin E
(IgE) responsiveness, other inflammatory
responses, and bronchial hyperresponsive-
ness, rather than on genetic markers of clini-
cal asthma. Presence of high levels of IgE
and bronchial hyperresponsiveness predict
asthma in subjects without diagnosed
asthma and occur more commonly in asth-
matic than in nonasthmatic subjects. For
each of these manifestations of asthma (phe-
notypes), there may be a gene or set of genes
that confer susceptibility or predisposition
(28–31). However, the inheritance patterns
of the disease indicate that it is not a simple
Mendelian trait; rather, asthma is a complex
disease involving several genetic and envi-
ronmental factors (29). We used parental
asthma and hay fever to represent the com-
plex genetic background of asthma that is
inherited by the child from the parents. The
strong relations between paternal and partic-
ularly maternal asthma and the development
of childhood asthma provide empirical sup-
port for the use of hereditary asthma to rep-
resent the genetic determinants of asthma.
Concluding remarks. The results show
that the joint effect of hereditary atopy rep-
resenting genetic constitution and environ-
mental tobacco smoke is stronger than
expected on the basis of their independent
effects. This phenomenon—effect modiﬁca-
tion of environmental exposure by genetic
constitution, or gene by environment inter-
action—suggests that some genetic markers
could indicate susceptibility to environmen-
tal factors. Identiﬁcation of these markers is
an interesting challenge for future studies.
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